European Code against Cancer 4th Edition: Obesity, body fatness and cancer

Cancer Epidemiology

Volumn 39, Issue , 2015, Pages S34-S45

  Anderson, Annie S ^a   Key, Timothy J ^b   Norat, Teresa ^c   Scoccianti, Chiara ^d   Cecchini, Michele ^e   Berrino, Franco ^f   Boutron Ruault, Marie Christine ^g   Espina, Carolina ^d   Leitzmann, Michael ^h   Powers, Hilary ⁱ   Wiseman, Martin ^j   Romieu, Isabelle ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e OECD   (France)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^j WORLD CANCER RESEARCH FUND INTERNATIONAL   (United Kingdom)

more..

Author keywords

BMI; Body fat; Cancer; Central obesity; Europe; Obesity; Primary prevention; Weight

Indexed keywords

ARTICLE; BODY FAT; BODY MASS; BREAST FEEDING; CALORIC INTAKE; CANCER RISK; CANCER SURVIVOR; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HEART DISEASE; HUMAN; LIFESTYLE; MEDICAL SOCIETY; NEOPLASM; OBESITY; PREVALENCE; PRIORITY JOURNAL; ADIPOSE TISSUE; COMPLICATION; EUROPEAN UNION; NEOPLASMS; PATHOLOGY; PRACTICE GUIDELINE; RISK FACTOR; STANDARDS;

ADIPOSE TISSUE; EUROPEAN UNION; GUIDELINES AS TOPIC; HUMANS; NEOPLASMS; OBESITY; OVERWEIGHT; RISK FACTORS;

EID: 84937597407     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.01.017     Document Type: Article

References (96)

1. [1] Eurostat database, 2013 http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Overweight_and_obesity_-_BMI_statistics.
2. [2] OECD, Health at a glance: Europe 2012. 2012, OECD Publishing.
3. [3] Eurostat database, http://epp.eurostat.ec.europa.eu/portal/page/portal/health/health_status_determinants/data/database.
4. [4] Kopelman, P., Jebb, S.A., Butland, B., Foresight: tackling obesities: future choices – project report. London: Government office for science. Obes Rev 8:Suppl. 1 (2007), vi–ix.
5. [5] World Cancer Research Fund/American Institute for Cancer Research, Policy and action for cancer prevention. food, nutrition and physical activity: a global perspective. 2009, AICR, Washington DC.
6. [6] Te Morenga, L., Mallard, S., Mann, J., Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ, 15(346), 2012, e7492.
7. [7] World Cancer Research Fund/American Institute for Cancer Research, Food, nutrition, physical activity, and the prevention of cancer: a global perspective. 2007, AICR, Washington, DC.
8. [8] Boulos, R., Vikre, E.K., Oppenheimer, S., Chang, H., Kanarek, R.B., ObesiTV: how television is influencing the obesity epidemic. Physiol Behav 107:1 (2012), 146–153.
9. [9] Weng, S.F., Redsell, S.A., Swift, J.A., Yang, M., Glazebrook, C.P., Systematic review and meta-analyses of risk factors for childhood overweight identifiable during infancy. Arch Dis Child 97:12 (2012), 1019–1026.
10. [10] Singh, A.S., Mulder, C., Twisk, J.W., van Mechelen, W., Chinapaw, M.J., Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev 9:5 (2008), 474–488.
11. [11] Ip, S., Chung, M., Raman, G., Chew, P., Magula, N., DeVine, D., et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess 153 (2007), 1–186 (Full Rep).
12. [12] Butte, N.F., The role of breastfeeding in obesity. Pediatr Clin North Am 48:1 (2001), 189–198.
13. [13] Baker, J.L., Gamborg, M., Heitmann, B.L., Lissner, L., Sørensen, T.I., Rasmussen, K.M., Breastfeeding reduces postpartum weight retention. Am J Clin Nutr 88:6 (2008), 1543–1551.
14. [14] Gunderson, E.P., Hedderson, M.M., Chiang, V., Crites, Y., Walton, D., Azevedo, R.A., et al. Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care 35:1 (2012), 50–56.
15. [15] O'Reilly, M., Avalos, G., Dennedy, M.C., O'Sullivan, E.P., Dunne, F.P., Breast-feeding is associated with reduced postpartum maternal glucose intolerance after gestational diabetes. Ir Med J 105:Suppl. 5 (2012), 31–36.
16. [16] Gunderson, E.P., Jacobs, D.R. Jr., Chiang, V., Lewis, C.E., Feng, J., Quesenberry, C.P. Jr., et al. Duration of lactation and incidence of the metabolic syndrome in women of reproductive age according to gestational diabetes mellitus status: a 20-Year prospective study in CARDIA (Coronary Artery Risk Development in Young Adults). Diabetes 59:2 (2010), 495–504.
17. [17] Bobrow, K.L., Quigley, M.A., Green, J., Reeves, G.K., Beral, V., Million Women Study, Collaborators., Persistent effects of women's parity and breastfeeding patterns on their body mass index: results from the Million Women Study. Int J Obes 37:5 (2012), 712–717.
18. [18] Oken, E., Patel, R., Guthrie, L.B., Vilchuck, K., Bogdanovich, N., Sergeichick, N., et al. Effects of an intervention to promote breastfeeding on maternal adiposity and blood pressure at 11.5 y postpartum: results from the Promotion of Breastfeeding Intervention Trial, a cluster-randomized controlled trial. Am J Clin Nutr 98:4 (2013), 1048–1056.
19. [19] Renehan, A.G., Soerjomataram, I., Tyson, M., Egger, M., Zwahlen, M., Coebergh, J.W., et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 126:3 (2010), 692–702.
20. [20] Parkin, D.M., Boyd, L., Walker, L.C., The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 105:Suppl. 2 (2011), S77–S81.
21. [21] World Cancer Research Fund (WCRF)2014UK preventability estimates from the http://www.wcrf-uk.org/uk/preventing-cancer/lifestyle-statistics/body-fatness. Last accessed 291214.
22. [22] Anonymous, IARC handbooks of cancer prevention. Weight control and physical activity. 2002, IARC Press. International Agency for Research on Cancer, Lyon, France.
23. [23] World Cancer Research Fund (WCRF)/American Institute for Cancer Research, Food, nutrition, physical activity and the prevention of cancer: a global perspective. 2013 http://www.dietandcancerreport.org/expert_report/report_contents/index.php.
24. [24] Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., Zwahlen, M., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:9612 (2008), 569–578.
25. [25] Chen, Y., Liu, L., Wang, X., Wang, J., Yan, Z., Cheng, J., et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. CEBP 22:8 (2013), 1395–1408.
26. [26] Discacciati, A., Orsini, N., Wolk, A., Body mass index and incidence of localized and advanced prostate cancer-a dose-response meta-analysis of prospective studies. Ann Oncol 23:7 (2012), 1665–1671.
27. [27] World Cancer Research Fund International, Diet, nutrition, physical activity and prostate cancer. 2014 http://www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf.
28. [28] Suzuki, R., Orsini, N., Saji, S., Key, T.J., Wolk, A., Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status – a meta-analysis. Int J Cancer 124:3 (2009), 698–712.
29. [29] Crosbie, E.J., Zwahlen, M., Kitchener, H.C., Egger, M., Renehan, A.G., Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. CEBP 19:12 (2010), 3119–3130.
30. [30] Rinaldi, S., Lise, M., Clavel-Chapelon, F., Boutron-Ruault, M.C., Guillas, G., Overvad, K., et al. Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 131:6 (2012), E1004–E1014.
31. [31] Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med, 9(4), 2012, e1001200.
32. [32] Ritte, R., Lukanova, A., Berrino, F., Dossus, L., Tjønneland, A., Olsen, A., et al. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res, 14(3), 2012, R76.
33. [33] Aleksandrova, K., Nimptsch, K., Pischon, T., Obesity and colorectal cancer. Front Biosci 5 (2013), 61–77.
34. [34] Britton, K.A., Massaro, J.M., Murabito, J.M., Kreger, B.E., Hoffmann, U., Fox, C.S., Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 62:10 (2013), 921–925.
35. [35] Calle, E.E., Kaaks, R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:8 (2004), 579–591.
36. [36] Hursting, S.D., Digiovanni, J., Dannenberg, A.J., Azrad, M., Leroith, D., Demark-Wahnefried, W., et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res 5:11 (2012), 1260–1272.
37. [37] Kaaks, R., Lukanova, A., Kurzer, M.S., Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. CEBP 11:12 (2002), 1531–1543.
38. [38] Key, T.J., Pike, M.C., The dose-effect relationship between ‘unopposed’ oestrogen and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer. Br J Cancer 57:2 (1998), 205–212.
39. [39] Gallagher, E.J., LeRoith, D., Minireview: IGF, insulin, and cancer. Endocrinology 152:7 (2011), 2546–2551.
40. [40] Jenab, M., Riboli, E., Cleveland, R.J., Norat, T., Rinaldi, S., Nieters, A., et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:2 (2007), 368–376.
41. [41] Michaud, D.S., Wolpin, B., Giovannucci, E., Liu, S., Cochrane, B., Manson, J.E., et al. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. CEBP 16:10 (2007), 2101–2109.
42. [42] Cust, A.E., Kaaks, R., Friedenreich, C. Al., Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 92:1 (2007), 255–263.
43. [43] Verheus, M., Peeters, P.H., Rinaldi, S., Dossus, L., Biessy, C., Olsen, A., et al. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119:3 (2006), 659–667.
44. [44] Chlebowski, R.T., McTiernan, A., Wactawski-Wende, J., Manson, J.E., Aragaki, A.K., Rohan, T., et al. Diabetes, metformin and breast cancer in postmenopausal women. J Clin Oncol 30:23 (2012), 2844–2852.
45. [45] Thakkar, B., Aronis, K.N., Vamvini, M.T., Shields, K., Mantzoros, C.S., Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies. Metabolism 62:7 (2013), 922–934.
46. [46] Roddam, A.W., Allen, N.E., Appleby, P., Key, T.J., Ferrucci, L., Carter, H.B., et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149:7 (2008), 461–471.
47. [47] Endogenous Hormones, Breast Cancer Collaborative Group, Key, T.J., Appleby, P.N., Reeves, G.K., Roddam, A.W., Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:6 (2010), 530–542.
48. [48] Pollak, M., Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:12 (2008), 915–928.
49. [49] Tworoger, S.S., Eliassen, A.H., Kelesidis, T., Colditz, G.A., Willett, W.C., Mantzoros, C.S., et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:4 (2007), 1510–1516.
50. [50] Wei, E.K., Giovannucci, E., Fuchs, C.S., Willett, W.C., Mantzoros, C.S., Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97:22 (2005), 1688–1694.
51. [51] Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation. Nature 454:7203 (2008), 436–444.
52. [52] Lagergren, J., Bergström, R., Lindgren, A., Nyrén, O., Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999), 825–831.
53. [53] Crowell, M.D., Bradley, A., Hansel, S., Dionisio, P., Kim, H.J., Decker, G.A., et al. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol 104 (2009), 553–559.
54. [54] Norat, T., Scoccianti, C., Boutron-Ruault, M.-C., Anderson, A., Berrino, F., Cecchini, M., et al. European Code against Cancer 4th Edition: Diet and cancer. Cancer Epidemiology 39 (2015), S56–S66.
55. [55] Scoccianti, C., Cecchini, M., Anderson, A.S., Berrino, F., Boutron-Ruault, M.-C., Espina, C., et al. European Code against Cancer 4th Edition: Alcohol drinking and cancer. Cancer Epidemiology 39 (2015), S67–S74.
56. [56] Leitzmann, M., Powers, H., Anderson, A.S., Scoccianti, C., Berrino, F., Boutron-Ruault, M.-C., Cecchini, M., et al. European Code against Cancer 4th Edition: Physical activity and cancer. Cancer Epidemiol 39 (2015), S46–S55.
57. [57] Chan, D.S., Viera, A.R., Aune, D., et al. Body mass index and survival in women with breast cancer – systematic literature review and meta-analysis of 82 follow-up studies. An Oncol(Apr), 2014, pii mdu042 (Epub ahead of print).
58. [58] World Cancer Research Fund International, Diet, nutrition, physical activity and breast cancer survivors. 2014 http://www.wcrf.org/sites/default/files/Breast-Cancer-Survivors-2014-Report.pdf.
59. [59] Protani, M.M., Nagle, C.M., Webb, P.M., Obesity and ovarian cancer survival: a systematic review and meta-analysis. Cancer Prev Res 5:7 (2012), 901–910.
60. [60] Arem, H., Park, Y., Pelser, C., et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst 105:5 (2013), 342–349.
61. [61] Calle, E.E., Rodriguez, C., Walker-Thurmond, K., Thun, M.J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003), 1625–1638.
62. [62] Giovannucci, E., Liu, Y., Platz, E.A., Stampfer, M.J., Willett, W.C., Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121 (2007), 1571–1578.
63. [63] Cao, Y., Ma, J., Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 4 (2011), 486–501.
64. [64] Dignam, J.J., Polite, B.N., Yothers, G., Raich, P., Colangelo, L., O'Connell, M.J., et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98 (2006), 1647–1654.
65. [65] Meyerhardt, J.A., Niedzwiecki, D., Hollis, D., Saltz, L.B., Mayer, R.J., Nelson, H., et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26 (2008), 4109–4115.
66. [66] Campbell, P.T., Newton, C.C., Dehal, A.N., Jacobs, E.J., Patel, A.V., Gapstur, S.M., Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30 (2012), 42–52.
67. [67] Demark-Wahnefried, W., Platz, E.A., Ligibel, J.A., Blair, C.K., Courneya, K.S., Meyerhardt, J.A., et al. The role of obesity in cancer survival and recurrence. CEBP 21:8 (2013), 1244–1259.
68. [68] Chlebowski, R.T., Blackburn, G.L., Thomson, C.A., Nixon, D.W., Shapiro, A., Hoy, M.K., et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98 (2006), 1767–1776.
69. [69] Klabunde, C.N., Legler, J.M., Warren, J.L., Baldwin, L.M., Schrag, D., A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17 (2007), 584–590.
70. [70] Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., Vigneri, R., Diabetes and cancer. Endocr Relat Cancer 16:4 (2009), 1103–1123.
71. [71] Deng, L., Gui, Z., Zhao, L., Wang, J., Shen, L., Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 57:6 (2012), 1576–1585.
72. [72] Lee, J.Y., Jeon, I., Kim, J.W., Song, Y.S., Yoon, J.M., Park, S.M., Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer 23:3 (2013), 402–412.
73. [73] De Bruijn, K.M., Arends, L.R., Hansen, B.E., Leeflang, S., Ruiter, R., van Eijck, C.H., Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer. Br J Surg 100:11 (2013), 1421–1429.
74. [74] Whitlock, G., Lewington, S., Sherliker, P., et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373 (2009), 1083–1096.
75. [75] Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M.B., Overvad, K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:20 (2008), 2105–2120.
76. [76] Bamia, C., Halkjaer, J., Lagiou, P., Trichopoulos, D., Tjønneland, A., Berentzen, T.L., et al. Weight change in later life and risk of death amongst the elderly: the European Prospective Investigation into Cancer and Nutrition-Elderly Network on Ageing and Health study. J Intern Med 268:2 (2010), 133–144.
77. [77] Baumgartner, R.N., Koehler, K.M., Gallagher, D., Romero, L., Heymsfield, S.B., Ross, R.R., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:8 (1998), 755–763.
78. [78] Craigie, A.M., Lake, A.A., Kelly, S.A., Adamson, A.J., Mathers, J.C., Tracking of obesity-related behaviours from childhood to adulthood: a systematic review. Maturitas 70:3 (2011), 266–284.
79. [79] Pate, R.R., O'Neill, J.R., Liese, A.D., Janz, K.F., Granberg, E.M., Colabianchi, N., et al. Factors associated with development of excessive fatness in children and adolscents: a review of prospective studies. Obes Rev 14:8 (2013), 645–658.
80. [80] Freedman, D.S., Khan, L.K., Serdula, M.K., Dietz, W.H., Srinivasan, S.R., Berenson, G.S., The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics 115 (2005), 22–27.
81. [81] Jefferys, M., Smith, G.D., Martin, R.M., Frankel, S., Gunnell, D., Childhood body mass index and later cancer risk: a 50-year follow-up of the Boyd Orr Study. Int J Cancer 112:2 (2004), 348–353.
82. [82] Park, M.H., Falconer, C., Viner, R.M., Kinra, S., The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review. Obes Rev 13:11 (2012), 985–1000.
83. [83] Scientific Advisory Committee on Nutrition, The influence of maternal, fetal and child nutrition on the development of chronic disease in later life. 2011, The Stationery Office Limited, London.
84. [84] Institute of Medicine of the National Academies, Breast cancer and the environment – a life course approach. 2011, The National Academies Press.
85. [85] Byers, T., Sedjo, R.L., Does intentional weight loss reduce cancer risk?. Diabetes Obes Metab 13 (2011), 1063–1072.
86. [86] Birks, S., Peeters, A., Backholer, K., O'Brien, P., Brown, W., A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev 13:10 (2012), 868–891.
87. [87] Campbell, K.L., Foster-Schubert, K.E., Alfano, C.M., Reduced calorie dietary weight loss, exercise and sex hormones in postmenopausal women: randomized control trial. J Clin Oncol 30:19 (2012), 2314–2326.
88. [88] Bardou, M., Barkun, A.N., Martel, M., Obesity and colorectal cancer. Gut 62:6 (2013), 933–947.
89. [89] Rapp, K., Klenk, J., Ulmer, H., Concin, H., Diem, G., Oberaigner, W., et al. Weight change and cancer risk in a cohort of more than 65,000 adults in Austria. Ann Oncol 19 (2008), 641–648.
90. [90] World Health Organisation, Global database on body mass index. 2006 updated 2013 http://apps.who.int/bmi/index.jsp?introPage=intro.html.
91. [91] Ildaphonse, G., George, P.S., Mathew, A., Obesity and kidney cancer risk in men: a meta-analysis (1992-2008). Asian Pac J Cancer Prev 10:2 (2009), 279–286.
92. [92] Mathew, A., George, P.S., Ildaphonse, G., Obesity and kidney cancer risk in women: a meta-analysis (1992-2008). Asian Pac J Cancer Prev 10:3 (2009), 471–478.
93. [93] Wallin, A., Larsson, S.C., Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 47:11 (2011), 1606–1615.
94. [94] Larsson, S.C., Wolk, A., Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer 47:16 (2011), 2422–2430.
95. [95] WRCF, Continuous update project (CUP) systematic literature reviews. 2015 http://www.dietandcancerreport.org/cancer_resource_center/continuous_update_project.php.
96. [96] Wang, Y., Wang, B., Shen, F., Fan, J., Cao, H., Body mass index and riks of primary liver cancer: a meta-analysis of prospective studies. Oncologist 17:11 (2012), 1461–1468.